Direct Transcriptional Regulation of Human Hepatic Cytochrome P 450 3 A 4 ( CYP 3 A 4 ) by Peroxisome Proliferator – Activated Receptor Alpha ( PPAR a ) s
暂无分享,去创建一个
Ulrich M. Zanger | Oliver Burk | Georg Damm | Thomas S. Weiss | G. Damm | M. Schwab | T. Weiss | O. Burk | U. Zanger | K. Klein | Matthias Schwab | Maria Thomas | Britta Klumpp | Kathrin Klein | Mariam Thomas | Benjamin A. Kandel | B. Kandel | B. Klumpp
[1] Ramesh Ramakrishnan,et al. High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array , 2008, PloS one.
[2] Peter Neuhaus,et al. Sex is a major determinant of CYP3A4 expression in human liver , 2003, Hepatology.
[3] J. Pascussi,et al. Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. , 2008, Molecular pharmaceutics.
[4] R. Tukey,et al. Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation , 2007, Drug Metabolism and Disposition.
[5] Jeffrey S Moffit,et al. Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.
[6] Wooin Lee,et al. The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4 , 2003, Nature Medicine.
[7] Xingguo Cheng,et al. REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.
[8] M. Sakharkar,et al. Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of Human , 2009, BMC Genomics.
[9] Jasmine Chen,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Handschin,et al. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. , 2005, Archives of biochemistry and biophysics.
[11] Eric F. Johnson,et al. Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation , 2007, Drug metabolism reviews.
[12] B. Staels,et al. Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[13] Aiming Liu,et al. Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats , 2011, Pharmacological reports : PR.
[14] P. D. de Groot,et al. Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis , 2010, Nucleic acids research.
[15] Michael Müller,et al. Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and Human , 2009, PloS one.
[16] J. Auwerx,et al. The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs). , 2002, Journal of atherosclerosis and thrombosis.
[17] Paavo Honkakoski,et al. Inhibition and induction of human cytochrome P450 enzymes: current status , 2008, Archives of Toxicology.
[18] Andreas Zell,et al. Inferring statin-induced gene regulatory relationships in primary human hepatocytes , 2011, Bioinform..
[19] J. Pascussi,et al. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. , 2008, Annual review of pharmacology and toxicology.
[20] C. Wolf,et al. Quantitative Prediction of Human Pregnane X Receptor and Cytochrome P450 3A4 Mediated Drug-Drug Interaction in a Novel Multiple Humanized Mouse Line , 2011, Molecular Pharmacology.
[21] B. Staels,et al. Peroxisome Proliferator-activated Receptor α Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme* , 2003, Journal of Biological Chemistry.
[22] X. Chu,et al. Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes , 2009, Nucleic acids research.
[23] John Turk,et al. Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.
[24] M. Schwab,et al. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.
[25] C. Handschin,et al. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. , 2002, Molecular endocrinology.
[26] F. Staedtler,et al. Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. , 2003, Toxicology and applied pharmacology.
[27] Oliver Burk,et al. Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin* , 2001, The Journal of Biological Chemistry.
[28] Songtao Yu,et al. Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas PPARα: energy combustion, hypolipidemia, inflammation and cancer , 2022 .
[29] E. Carlini,et al. Comparative Effects of Fibrates on Drug Metabolizing Enzymes in Human Hepatocytes , 2004, Pharmaceutical Research.
[30] L. Wojnowski,et al. Evolutionary history and functional characterization of the amphibian xenosensor CAR. , 2012, Molecular endocrinology.
[31] W. Xie,et al. Targeting xenobiotic receptors PXR and CAR for metabolic diseases. , 2012, Trends in pharmacological sciences.
[32] B. Spiegelman,et al. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Buechler,et al. Does hepatic steatosis affect drug metabolizing enzymes in the liver? , 2011, Current drug metabolism.
[34] Ute Hofmann,et al. Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes , 2010, Drug Metabolism and Disposition.
[35] J. Lehmann,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] W. Wahli,et al. Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors , 2007, Cellular and Molecular Life Sciences.
[37] M. Eichelbaum,et al. Molecular Mechanism of Basal CYP3A4 Regulation by Hepatocyte Nuclear Factor 4α: Evidence for Direct Regulation in the Intestine , 2007, Drug Metabolism and Disposition.
[38] N. Plant,et al. TRANSCRIPTIONAL REGULATION OF THE PXR GENE: IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α BINDING SITE WITHIN THE PROXIMAL PROMOTER OF PXR , 2006, Drug Metabolism and Disposition.
[39] J. Pascussi,et al. CYP1A1 Induction in the Colon by Serum: Involvement of the PPARα Pathway and Evidence for a New Specific Human PPREα Site , 2011, PloS one.
[40] W. Wahli,et al. PPARs at the crossroads of lipid signaling and inflammation , 2012, Trends in Endocrinology & Metabolism.
[41] D. Waxman,et al. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. , 1999, Archives of biochemistry and biophysics.
[42] N. Anderson,et al. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis , 2008, Pharmacological Reviews.
[43] Michael Müller,et al. Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.
[44] K. Griffin,et al. Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] M. Niemi,et al. PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo , 2012, Clinical pharmacology and therapeutics.